Discovery of furopyridine-based compounds as novel inhibitors of Janus kinase 2: In silico and in vitro studies
Description
Janus kinase 2 (JAK2), one of the JAK isoforms participating in a JAK/STAT signaling cascade, has been considered a potential clinical target owing to its critical role in physiological processes involved in cell growth, survival, development, and
